Related Experiment Video
Updated: Aug 18, 2026
Expansion of Human Peripheral Blood γδ T Cells using Zoledronate
Published on: September 9, 2011
Effects of gamma-interferon on the endocrine system: results from a phase I study
D Goldstein1, J Gockerman, R Krishnan
1Department of Medicine, Duke Medical Center, Durham, North Carolina 27710.
Abstract:
Interferon causes profound biological changes when given to patients with cancer and many of these could not be predicted from in vitro or animal model systems. We documented significant changes in hormonal levels for a group of 18 patients who were participants in a Phase I gamma-interferon trial. Adrenocorticotropic hormone, cortisol, and growth hormone were all significantly elevated 2 h after treatment with gamma-interferon, with cortisol and adrenocorticotropic hormone returning to base line by 24 h. A placebo group failed to show this change, suggesting a specific interferon effect. Possible mechanisms for these findings and implications for the use of interferons are discussed.
Insights
Gamma-interferon treatment significantly altered hormone levels in cancer patients, including elevations in adrenocorticotropic hormone and cortisol. These findings highlight unpredictable biological effects of interferon therapy.
Area of Science:
- Oncology
- Endocrinology
- Immunology
Background:
- Interferon therapy in cancer patients can induce significant biological changes.
- Many of these effects are not predictable from in vitro or animal models.
- Understanding interferon's systemic effects is crucial for optimizing cancer treatment.
Purpose of the Study:
- To investigate the impact of gamma-interferon on hormonal levels in cancer patients.
- To identify specific hormonal changes induced by gamma-interferon administration.
- To differentiate interferon-specific effects from placebo responses.
Main Methods:
- A Phase I clinical trial involving 18 cancer patients receiving gamma-interferon.
- Measurement of hormonal levels (adrenocorticotropic hormone, cortisol, growth hormone) at baseline, 2 hours, and 24 hours post-treatment.
- Comparison of hormonal changes between the gamma-interferon group and a placebo group.
Main Results:
- Significant elevations in adrenocorticotropic hormone, cortisol, and growth hormone were observed 2 hours after gamma-interferon treatment.
- Cortisol and adrenocorticotropic hormone levels returned to baseline by 24 hours post-treatment.
- No significant hormonal changes were observed in the placebo group, indicating a specific interferon effect.
Conclusions:
- Gamma-interferon administration leads to acute, significant alterations in the endocrine system of cancer patients.
- The observed hormonal changes are specific to interferon treatment and not a general response to the trial conditions.
- Further research into the mechanisms and implications of these hormonal shifts is warranted for safe and effective interferon use in oncology.
